Mahller, Yonatan Y <br/><br/>
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Feb 2007 
 - 279-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0016 
<br/><br/><label>Standard No.: </label>10.1038/sj.mt.6300038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Chlorocebus aethiops<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Genetic Therapy--methods<br/>Humans<br/>Immunoblotting<br/>In Situ Hybridization<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Neovascularization, Pathologic--prevention & control<br/>Nerve Sheath Neoplasms--genetics<br/>Oligonucleotide Array Sequence Analysis<br/>Oncolytic Virotherapy--methods<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>Rabbits<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Simplexvirus--genetics<br/>Vero Cells<br/>Xenograft Model Antitumor Assays